| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0047 | 1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |